Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_136_24
Mojtaba Abrishami, Daniel J Weisbrod, Hatem Krema
Purpose: To report a case of presumed solitary circumscribed retinal astrocytic proliferation (PSCRAP) diagnosed through multimodal imaging.
Methods: A single case report documented with multimodal imaging.
Results: A 41-year-old asymptomatic female was referred for a second opinion regarding whitish retinal lesions in her left eye, first identified by her local optometrist 8 years prior. Her history included Hashimoto thyroiditis, with no personal or family history of tuberous sclerosis complex or neurofibromatosis. Visual acuity was 20/20 in both eyes. Fundoscopy of the left eye revealed two pearly white avascular retinal masses. Spectral-domain optical coherence tomography (SD-OCT) showed hyperreflective intraretinal masses with optical shadowing. Optical coherence tomography angiography (OCTA) demonstrated a signal void in the retinal vascular plexuses. Fundus autofluorescence showed moderate hyperautofluorescence. The lesions remained stable over 3 months.
Conclusions: PSCRAP is a rare, benign retinal tumor. Multimodal imaging, including SD-OCT and OCTA, is essential for accurate diagnosis, showing unique features such as separation from the retinal nerve fiber layer and lack of intrinsic vascularity. Our observation of two lesions raises questions about the solitary nature of this condition. Continued documentation may be necessary to differentiate from simulating lesions that may undergo subsequent growth.
{"title":"Presumed Solitary Circumscribed Retinal Astrocytic Proliferation: A Case Report.","authors":"Mojtaba Abrishami, Daniel J Weisbrod, Hatem Krema","doi":"10.4103/joco.joco_136_24","DOIUrl":"10.4103/joco.joco_136_24","url":null,"abstract":"<p><strong>Purpose: </strong>To report a case of presumed solitary circumscribed retinal astrocytic proliferation (PSCRAP) diagnosed through multimodal imaging.</p><p><strong>Methods: </strong>A single case report documented with multimodal imaging.</p><p><strong>Results: </strong>A 41-year-old asymptomatic female was referred for a second opinion regarding whitish retinal lesions in her left eye, first identified by her local optometrist 8 years prior. Her history included Hashimoto thyroiditis, with no personal or family history of tuberous sclerosis complex or neurofibromatosis. Visual acuity was 20/20 in both eyes. Fundoscopy of the left eye revealed two pearly white avascular retinal masses. Spectral-domain optical coherence tomography (SD-OCT) showed hyperreflective intraretinal masses with optical shadowing. Optical coherence tomography angiography (OCTA) demonstrated a signal void in the retinal vascular plexuses. Fundus autofluorescence showed moderate hyperautofluorescence. The lesions remained stable over 3 months.</p><p><strong>Conclusions: </strong>PSCRAP is a rare, benign retinal tumor. Multimodal imaging, including SD-OCT and OCTA, is essential for accurate diagnosis, showing unique features such as separation from the retinal nerve fiber layer and lack of intrinsic vascularity. Our observation of two lesions raises questions about the solitary nature of this condition. Continued documentation may be necessary to differentiate from simulating lesions that may undergo subsequent growth.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"296-299"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_9_24
Pedro Filipecki Mansilla, Vagner Loduca Lima, Gustavo Henrique Araújo Salomão, Denise Maria Christofolini
Purpose: To genetically investigate a family with a clinical and ophthalmological phenotype suggestive of Stickler syndrome (STL) and the association of molecular findings with ophthalmological, clinical characteristics, and family history.
Methods: Specialized ophthalmologic evaluation using diagnostic methods such as fundoscopy, slit-lamp photography, and ocular biometry to describe the phenotypic characteristics of the index patient and family members. Genetic evaluation with genome sequencing (WGS) is to describe the genotypic characteristics of the proband and confirmation of the finding by family-specific variant sequencing (NGS).
Results: Genetic evaluation demonstrated the presence of a novel pathogenic variant NM_001854.4: C.3168+1G>A (chr1:102961865-102961865), in the intronic region that follows exon 41 of the COL11A1 in the three affected members of the family. This variant is located 1 base from the natural splicing region of this exon and consequently can impact intron removal and protein formation. As for the ophthalmological findings, the presence of low visual acuity, high axial myopia, and pathological vitreous gel with a "beaded" appearance was observed in the index case. Further clinical examination showed that other family members also had vitreous and retinal degeneration.
Conclusions: A heterozygous novel pathogenic variant in COL11A1 was identified by complete genome sequencing in a Brazilian family with STL. Ocular examination findings photographically presented confirm the characteristic features of STL type 2.
目的:对一个具有提示Stickler综合征(STL)临床和眼科表型的家族进行遗传学研究,并分析其分子表现与眼科、临床特征和家族史的关系。方法:采用眼底镜检、裂隙灯摄影、眼生物测量等诊断方法对指数患者及其家属进行专业眼科评价。基因组测序遗传评价(WGS)是描述先证者的基因型特征,并通过家族特异性变异测序(NGS)证实这一发现。结果:遗传评估表明,在三个受影响家庭成员COL11A1外显子41后的内含子区域存在一种新的致病变异NM_001854.4: C.3168+1G> a (chr1:102961865-102961865)。该变异位于该外显子自然剪接区1个碱基之外,因此可以影响内含子的去除和蛋白质的形成。在眼科方面,指数病例可见低视力、高轴性近视,病理性玻璃体凝胶呈“珠状”外观。进一步的临床检查显示其他家庭成员也有玻璃体和视网膜变性。结论:通过全基因组测序,在巴西STL家族中发现了COL11A1的一种杂合新型致病变异。眼部检查结果证实STL 2型的特征。
{"title":"Genetic Variants in Rare Ophthalmological Syndromes: Novel <i>COL11A1</i> Splice Site Variant in a Brazilian Family with Stickler Syndrome Type 2.","authors":"Pedro Filipecki Mansilla, Vagner Loduca Lima, Gustavo Henrique Araújo Salomão, Denise Maria Christofolini","doi":"10.4103/joco.joco_9_24","DOIUrl":"10.4103/joco.joco_9_24","url":null,"abstract":"<p><strong>Purpose: </strong>To genetically investigate a family with a clinical and ophthalmological phenotype suggestive of Stickler syndrome (STL) and the association of molecular findings with ophthalmological, clinical characteristics, and family history.</p><p><strong>Methods: </strong>Specialized ophthalmologic evaluation using diagnostic methods such as fundoscopy, slit-lamp photography, and ocular biometry to describe the phenotypic characteristics of the index patient and family members. Genetic evaluation with genome sequencing (WGS) is to describe the genotypic characteristics of the proband and confirmation of the finding by family-specific variant sequencing (NGS).</p><p><strong>Results: </strong>Genetic evaluation demonstrated the presence of a novel pathogenic variant NM_001854.4: C.3168+1G>A (chr1:102961865-102961865), in the intronic region that follows exon 41 of the <i>COL11A1</i> in the three affected members of the family. This variant is located 1 base from the natural splicing region of this exon and consequently can impact intron removal and protein formation. As for the ophthalmological findings, the presence of low visual acuity, high axial myopia, and pathological vitreous gel with a \"beaded\" appearance was observed in the index case. Further clinical examination showed that other family members also had vitreous and retinal degeneration.</p><p><strong>Conclusions: </strong>A heterozygous novel pathogenic variant in <i>COL11A1</i> was identified by complete genome sequencing in a Brazilian family with STL. Ocular examination findings photographically presented confirm the characteristic features of STL type 2.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"304-306"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_285_23
Rushil Kumbhani, Amanda Wong, Aretha Zhu, Paras Shah, Tristan Tham, Farihah Anwar, Daniel Zhu
Purpose: To perform a meta-analysis to compare the efficacy of selective laser trabeculoplasty (SLT) in phakic and pseudophakic eyes.
Methods: Scopus, Embase, PubMed, and gray literature were searched for studies comparing SLT outcomes in phakic and pseudophakic patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). The mean change in intraocular pressure was compared using a standardized mean difference (SMD) meta-analysis (RevMan 5.4.1). Begg's funnel plots and Egger's test were used to assess publication bias.
Results: Eleven studies with 1058 eyes (323 pseudophakic and 735 phakic) were identified. There was no statistically significant difference in the observed efficacy of SLT between pseudophakic and phakic eyes (SMD = -0.10; 95% confidence interval = -0.24, 0.03; P = 0.14). There was no publication bias or heterogeneity (I2 = 0%; P = 0.66) detected. Subgroup analysis of studies stratified by length of follow-up in months (6, 12, and 24 or greater) revealed no significant difference in SLT efficacy at the different time points (P = 0.86, P = 0.59, and P = 0.16, respectively).
Conclusions: Our pooled and subgroup analysis revealed no significant difference in SLT response between the two populations. Our results support SLT as a viable treatment option for patients with OAG or OHT regardless of pseudophakic status.
{"title":"Selective Laser Trabeculoplasty Outcomes in Phakic and Pseudophakic Patients: A Meta-Analysis.","authors":"Rushil Kumbhani, Amanda Wong, Aretha Zhu, Paras Shah, Tristan Tham, Farihah Anwar, Daniel Zhu","doi":"10.4103/joco.joco_285_23","DOIUrl":"10.4103/joco.joco_285_23","url":null,"abstract":"<p><strong>Purpose: </strong>To perform a meta-analysis to compare the efficacy of selective laser trabeculoplasty (SLT) in phakic and pseudophakic eyes.</p><p><strong>Methods: </strong>Scopus, Embase, PubMed, and gray literature were searched for studies comparing SLT outcomes in phakic and pseudophakic patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). The mean change in intraocular pressure was compared using a standardized mean difference (SMD) meta-analysis (RevMan 5.4.1). Begg's funnel plots and Egger's test were used to assess publication bias.</p><p><strong>Results: </strong>Eleven studies with 1058 eyes (323 pseudophakic and 735 phakic) were identified. There was no statistically significant difference in the observed efficacy of SLT between pseudophakic and phakic eyes (SMD = -0.10; 95% confidence interval = -0.24, 0.03; <i>P</i> = 0.14). There was no publication bias or heterogeneity (<i>I</i> <sup>2</sup> = 0%; <i>P</i> = 0.66) detected. Subgroup analysis of studies stratified by length of follow-up in months (6, 12, and 24 or greater) revealed no significant difference in SLT efficacy at the different time points (<i>P</i> = 0.86, <i>P</i> = 0.59, and <i>P</i> = 0.16, respectively).</p><p><strong>Conclusions: </strong>Our pooled and subgroup analysis revealed no significant difference in SLT response between the two populations. Our results support SLT as a viable treatment option for patients with OAG or OHT regardless of pseudophakic status.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"242-251"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_79_24
Hassan Hashemi, Abbasali Yekta, Mohammadreza Aghamirsalim, Alireza Hashemi, Mehdi Khabazkhoob
Purpose: To determine the distribution of corneal higher-order aberrations (HOAs) measured by pentacam HR in a rural Iranian population and their relationship with age, sex, and refractive errors.
Methods: In this study, sampling was performed from villages in the north and southwest of Iran using the multistage stratified random cluster sampling method. The ocular examination included measurement of uncorrected and best-corrected visual acuity, refraction, and slit-lamp biomicroscopy. Finally, all study participants underwent corneal imaging using Pentacam HR.
Results: The mean root-mean-square (RMS) (±standard error) of total HOA in the anterior and posterior corneal surfaces was 0.498 ± 0.004 μm and 0.212 ± 0.001 μm, respectively. The mean RMS of anterior and posterior spherical aberration was 0.270 ± 0.002 μm and -0.134 ± 0.001 μm, respectively. The mean RMS of anterior horizontal and vertical coma was -0.084 ± 0.003 μm and 0.029 ± 0.004 μm, respectively. The mean RMS of posterior horizontal and vertical coma was 0.011 ± 0.001 μm and -0.011 ± 0.001 μm, respectively. The anterior HOAs were significantly different between age, sex, and refractive groups (all P < 0.05). The total anterior HOA had a statistically significant relationship with the male sex, older age, higher mean keratometry (K), and hyperopia. The anterior spherical aberration was significantly directly related to age, mean K, and hyperopia and inversely related to myopia.
Conclusions: The amounts of HOAs in the present study were different from previous studies, and these residence place differences (urban/rural) in the HOAs should be taken into account when designing refractive surgery nomograms and therapeutic and diagnostic considerations in each population. Moreover, the corneal HOAs, especially on the anterior surface, increased significantly with aging.
{"title":"Evaluation of Corneal Higher-Order Aberrations by Pentacam HR in Rural Population of Iran.","authors":"Hassan Hashemi, Abbasali Yekta, Mohammadreza Aghamirsalim, Alireza Hashemi, Mehdi Khabazkhoob","doi":"10.4103/joco.joco_79_24","DOIUrl":"10.4103/joco.joco_79_24","url":null,"abstract":"<p><strong>Purpose: </strong>To determine the distribution of corneal higher-order aberrations (HOAs) measured by pentacam HR in a rural Iranian population and their relationship with age, sex, and refractive errors.</p><p><strong>Methods: </strong>In this study, sampling was performed from villages in the north and southwest of Iran using the multistage stratified random cluster sampling method. The ocular examination included measurement of uncorrected and best-corrected visual acuity, refraction, and slit-lamp biomicroscopy. Finally, all study participants underwent corneal imaging using Pentacam HR.</p><p><strong>Results: </strong>The mean root-mean-square (RMS) (±standard error) of total HOA in the anterior and posterior corneal surfaces was 0.498 ± 0.004 μm and 0.212 ± 0.001 μm, respectively. The mean RMS of anterior and posterior spherical aberration was 0.270 ± 0.002 μm and -0.134 ± 0.001 μm, respectively. The mean RMS of anterior horizontal and vertical coma was -0.084 ± 0.003 μm and 0.029 ± 0.004 μm, respectively. The mean RMS of posterior horizontal and vertical coma was 0.011 ± 0.001 μm and -0.011 ± 0.001 μm, respectively. The anterior HOAs were significantly different between age, sex, and refractive groups (all <i>P</i> < 0.05). The total anterior HOA had a statistically significant relationship with the male sex, older age, higher mean keratometry (K), and hyperopia. The anterior spherical aberration was significantly directly related to age, mean K, and hyperopia and inversely related to myopia.</p><p><strong>Conclusions: </strong>The amounts of HOAs in the present study were different from previous studies, and these residence place differences (urban/rural) in the HOAs should be taken into account when designing refractive surgery nomograms and therapeutic and diagnostic considerations in each population. Moreover, the corneal HOAs, especially on the anterior surface, increased significantly with aging.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"258-266"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_261_24
Saurabh RamBihariLal Shrivastava
{"title":"Comment on \"Evaluation and Comparison of the Knowledge Levels of Current Artificial Intelligence Programs on Retinal/Vitreous Diseases and Treatment Methods\".","authors":"Saurabh RamBihariLal Shrivastava","doi":"10.4103/joco.joco_261_24","DOIUrl":"10.4103/joco.joco_261_24","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"312-313"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_266_24
Eyupcan Sensoy, Mehmet Citirik
{"title":"Reply to Comment on \"Evaluation and Comparison of the Knowledge Levels of Current Artificial Intelligence Programs on Retinal/Vitreous Diseases and Treatment Methods\".","authors":"Eyupcan Sensoy, Mehmet Citirik","doi":"10.4103/joco.joco_266_24","DOIUrl":"10.4103/joco.joco_266_24","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"311"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_133_24
Shahin Faghihi, Hooshang Faghihi, Mir Alborz Faiez, Abbas Mohammadi, Esmaeil Asadi Khameneh, Elias Khalili Pour, Hamid Riazi-Esfahani
Purpose: To comprehensively review and evaluate the therapeutic strategies for persistent diabetic macular edema (DME), with a particular emphasis on established treatments. Furthermore, the study explores emerging and innovative therapeutic options.
Methods: A nonsystematic search was carried out using PubMed, Cochrane, Medline, and Google Scholar databases with the keywords "macular edema", "persistent", "diabetic", "therapeutic", and "emerging". We specifically looked for experimental studies, randomized clinical trials, and retrospective and prospective studies without limiting the search timeframe for the articles up to December 2023.
Results: This review delineates a comprehensive array of treatment modalities for persistent DME, encompassing anti-vascular endothelial growth factor (anti-VEGF) switching, corticosteroids, laser therapies, combination therapy, and surgical approaches. Additionally, emerging treatments were explored, featuring novel anti-VEGF agents, innovative surgical techniques, as well as inhibitors targeting Angiopoietin-2 and the Kallikrein-Kinin System.
Conclusions: It is important to employ personalized and evidence-based approaches in addressing persistent DME. The ongoing advancement in treatment paradigms will play a crucial role in the continual evolution of DME management.
{"title":"Persistent Diabetic Macular Edema: A Comprehensive Review of Current Treatments and Emerging Therapeutic Options.","authors":"Shahin Faghihi, Hooshang Faghihi, Mir Alborz Faiez, Abbas Mohammadi, Esmaeil Asadi Khameneh, Elias Khalili Pour, Hamid Riazi-Esfahani","doi":"10.4103/joco.joco_133_24","DOIUrl":"10.4103/joco.joco_133_24","url":null,"abstract":"<p><strong>Purpose: </strong>To comprehensively review and evaluate the therapeutic strategies for persistent diabetic macular edema (DME), with a particular emphasis on established treatments. Furthermore, the study explores emerging and innovative therapeutic options.</p><p><strong>Methods: </strong>A nonsystematic search was carried out using PubMed, Cochrane, Medline, and Google Scholar databases with the keywords \"macular edema\", \"persistent\", \"diabetic\", \"therapeutic\", and \"emerging\". We specifically looked for experimental studies, randomized clinical trials, and retrospective and prospective studies without limiting the search timeframe for the articles up to December 2023.</p><p><strong>Results: </strong>This review delineates a comprehensive array of treatment modalities for persistent DME, encompassing anti-vascular endothelial growth factor (anti-VEGF) switching, corticosteroids, laser therapies, combination therapy, and surgical approaches. Additionally, emerging treatments were explored, featuring novel anti-VEGF agents, innovative surgical techniques, as well as inhibitors targeting Angiopoietin-2 and the Kallikrein-Kinin System.</p><p><strong>Conclusions: </strong>It is important to employ personalized and evidence-based approaches in addressing persistent DME. The ongoing advancement in treatment paradigms will play a crucial role in the continual evolution of DME management.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"229-241"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_107_24
Pradeep Agarwal, Veenu Maan, Ashi Khurana, Samir Sutar, Lokesh Chauhan
Purpose: To assess the safety and efficacy of the 4-year administration of 0.01% atropine following a 1-year observation period in high myopic children.
Methods: The RAMCOM-II study continues the RAMCOM study, designed as an interventional nonrandomized study. Participants were observed for 1 year without any intervention to establish a baseline. Subsequently, children were divided into two arms: participants in the intervention group received one drop of 0.01% atropine daily at bedtime from years 1 to 5, while the control arm received no treatment and was monitored with routine clinical examinations. Annual assessments captured myopia progression, visual acuity, adverse events, and compliance. Statistical analyses compared outcomes between the two groups, considering demographic factors.
Results: At the 4-year follow-up, myopia progression from baseline in the intervention group (atropine-treated eyes) was significantly lower than in the control group (2.0 ± 2.0 diopter [D] vs. 3.2 ± 1.9 D, P = 0.01). Axial elongation also favored the intervention group. At the 5-year follow-up, similar trends persisted, underscoring the sustained efficacy of 0.01% atropine. Myopia progression remained significantly reduced in the intervention group compared to the control group (2.2 ± 2.0 D vs. 3.4 ± 1.9 D, P = 0.01). Although differences in axial elongation were less pronounced, these findings highlight the long-term benefits of 0.01% atropine in managing high myopia in children.
Conclusion: The RAMCOM-II study supports the efficacy of 0.01% atropine in controlling myopia progression over 5 years, emphasizing its promising role in pediatric high myopia management.
目的:评价0.01%阿托品治疗高度近视儿童1年观察期后4年的安全性和有效性。方法:RAMCOM- ii研究延续RAMCOM研究,设计为介入性非随机研究。参与者在没有任何干预的情况下观察了1年以建立基线。随后,将儿童分为两组:干预组的参与者从1岁到5岁每天睡前服用0.01%的阿托品,而对照组的参与者不接受任何治疗,并进行常规临床检查监测。年度评估包括近视进展、视力、不良事件和依从性。统计分析比较了两组的结果,考虑了人口因素。结果:随访4年时,干预组(阿托品治疗眼)的近视进展较对照组明显降低(2.0±2.0屈光度[D]∶3.2±1.9 D, P = 0.01)。轴向伸长也有利于干预组。在5年的随访中,类似的趋势持续存在,强调0.01%阿托品的持续疗效。与对照组相比,干预组的近视进展仍显著减少(2.2±2.0 D vs. 3.4±1.9 D, P = 0.01)。虽然轴向伸长的差异不太明显,但这些发现强调了0.01%阿托品在治疗儿童高度近视中的长期益处。结论:RAMCOM-II研究支持0.01%阿托品在5年内控制近视进展的有效性,强调了其在小儿高度近视治疗中的重要作用。
{"title":"A Longitudinal Study Evaluating the Impact of 0.01% Atropine in High Myopic Children (RAMCOM-II Study).","authors":"Pradeep Agarwal, Veenu Maan, Ashi Khurana, Samir Sutar, Lokesh Chauhan","doi":"10.4103/joco.joco_107_24","DOIUrl":"10.4103/joco.joco_107_24","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the safety and efficacy of the 4-year administration of 0.01% atropine following a 1-year observation period in high myopic children.</p><p><strong>Methods: </strong>The RAMCOM-II study continues the RAMCOM study, designed as an interventional nonrandomized study. Participants were observed for 1 year without any intervention to establish a baseline. Subsequently, children were divided into two arms: participants in the intervention group received one drop of 0.01% atropine daily at bedtime from years 1 to 5, while the control arm received no treatment and was monitored with routine clinical examinations. Annual assessments captured myopia progression, visual acuity, adverse events, and compliance. Statistical analyses compared outcomes between the two groups, considering demographic factors.</p><p><strong>Results: </strong>At the 4-year follow-up, myopia progression from baseline in the intervention group (atropine-treated eyes) was significantly lower than in the control group (2.0 ± 2.0 diopter [D] vs. 3.2 ± 1.9 D, <i>P</i> = 0.01). Axial elongation also favored the intervention group. At the 5-year follow-up, similar trends persisted, underscoring the sustained efficacy of 0.01% atropine. Myopia progression remained significantly reduced in the intervention group compared to the control group (2.2 ± 2.0 D vs. 3.4 ± 1.9 D, <i>P</i> = 0.01). Although differences in axial elongation were less pronounced, these findings highlight the long-term benefits of 0.01% atropine in managing high myopia in children.</p><p><strong>Conclusion: </strong>The RAMCOM-II study supports the efficacy of 0.01% atropine in controlling myopia progression over 5 years, emphasizing its promising role in pediatric high myopia management.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"291-295"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184860/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To evaluate the agreement between topographical and tomographic measurements of the cornea with three methods of Placido-disc, Scheimpflug, and optical coherence tomography in normal eyes with myopic refractive error candidate for keratorefractive surgery.
Methods: Subjects within the age range of 18-55 years old candidates for keratorefractive surgery with no history of systemic disorder, eye diseases except refractive errors, and ocular surgery were enrolled in the study. The intraclass correlation coefficient and Bland-Altman diagrams evaluated the agreement between different devices.
Results: In this study, 97 subjects, including 35 men and 62 women, participated. There was a statistically significant agreement between the three corneal imaging devices' keratometry measures. Bland-Altman plots show a mean difference of 0.5 diopter (D) for mean anterior keratometry, and 95% limits of agreement reached the value ± 1.00 D for mean anterior astigmatism. Evaluation of the elevation maps showed that the central and maximum elevation of the cornea's anterior and posterior surfaces with Pentacam and Optopol have poor agreement.
Conclusion: Despite an excellent statistical agreement, the differences in the anterior keratometry values may not be clinically acceptable.
{"title":"Agreement between Placido Disc, Scheimpflug, and Optical Coherence Tomography-Based Measurements of Corneal Topography in Healthy Myopic Individuals.","authors":"Siamak Zarei-Ghanavati, Mahtab Saber Moghaddam, Elham Bakhtiari, Sina Shirzad, Javad Sadeghi, Mehrdad Motamed Shariati","doi":"10.4103/joco.joco_152_24","DOIUrl":"10.4103/joco.joco_152_24","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the agreement between topographical and tomographic measurements of the cornea with three methods of Placido-disc, Scheimpflug, and optical coherence tomography in normal eyes with myopic refractive error candidate for keratorefractive surgery.</p><p><strong>Methods: </strong>Subjects within the age range of 18-55 years old candidates for keratorefractive surgery with no history of systemic disorder, eye diseases except refractive errors, and ocular surgery were enrolled in the study. The intraclass correlation coefficient and Bland-Altman diagrams evaluated the agreement between different devices.</p><p><strong>Results: </strong>In this study, 97 subjects, including 35 men and 62 women, participated. There was a statistically significant agreement between the three corneal imaging devices' keratometry measures. Bland-Altman plots show a mean difference of 0.5 diopter (D) for mean anterior keratometry, and 95% limits of agreement reached the value ± 1.00 D for mean anterior astigmatism. Evaluation of the elevation maps showed that the central and maximum elevation of the cornea's anterior and posterior surfaces with Pentacam and Optopol have poor agreement.</p><p><strong>Conclusion: </strong>Despite an excellent statistical agreement, the differences in the anterior keratometry values may not be clinically acceptable.</p>","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"272-278"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-06-05eCollection Date: 2024-07-01DOI: 10.4103/joco.joco_250_24
Hinpetch Daungsupawong, Viroj Wiwanitkit
{"title":"Current Artificial Intelligence Programs on Retinal/Vitreous Diseases and Treatment Methods.","authors":"Hinpetch Daungsupawong, Viroj Wiwanitkit","doi":"10.4103/joco.joco_250_24","DOIUrl":"10.4103/joco.joco_250_24","url":null,"abstract":"","PeriodicalId":15423,"journal":{"name":"Journal of Current Ophthalmology","volume":"36 3","pages":"310"},"PeriodicalIF":1.2,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144484576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}